Eli Lilly is reportedly in advanced negotiations to acquire biotech firm Kelonia Therapeutics for over $2 billion, potentially finalizing the…
Browsing: Lilly
Haisco Pharmaceutical Group has entered a licensing and research collaboration with Eli Lilly to develop new medicines across various therapeutic…
Summary of Key Developments: GSK Acquires Nuvalent: GSK is reviving its acquisition strategy after a decade, buying US biotech Nuvalent…
Eli Lilly’s next-generation obesity drug, retatrutide, has shown promising results in rapid weight loss and blood sugar reduction in people…
In 2026, global biopharma mergers and acquisitions have surged, with deal values reaching $106 billion across 201 transactions as of…
China’s Haisco Pharmaceutical Group has entered a $2.9 billion licensing and research collaboration with Eli Lilly to develop innovative medicines…
China’s Haisco Pharmaceutical Group has entered into a significant licensing and research collaboration with Eli Lilly, valued at $2.9 billion,…
Eli Lilly, Merck, and Pfizer are major players in the pharmaceutical industry, with Lilly leading in diabetes and weight management…
On May 29, 2026, Haisco Pharmaceutical Group announced a licensing and research collaboration with Eli Lilly to develop innovative medicines…
Eli Lilly (LLY) has announced its plan to acquire three biotech companies—Curevo, LimmaTech Biologics, and Vaccine Company—for a total of…